PASSAGE BIO, INC. Deferred Tax Liabilities, Property, Plant and Equipment
PASSAGE BIO, INC. (PASG) had Deferred Tax Liabilities, Property, Plant and Equipment of $336.00 thousand as of 2023-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2025-03-04
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $336.00K.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $813.00K.
- 2021-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $347.00K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2023-12-31 | $336.00K 10-K · filed 2025-03-04 |
| 2022-12-31 | $813.00K 10-K · filed 2024-03-04 |
| 2021-12-31 | $347.00K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |